scholarly article | Q13442814 |
P50 | author | Stanley Plotkin | Q7599873 |
P2093 | author name string | Lang J | |
Jaussaud R | |||
Blondeau C | |||
Strady A | |||
Lienard M | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | rabies vaccine | Q4007169 |
rabies | Q39222 | ||
antibody | Q79460 | ||
P304 | page(s) | 1290-1295 | |
P577 | publication date | 1998-05-01 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. | |
P478 | volume | 177 |
Q92263180 | A randomized open-label trial of 2-dose or 3-dose pre-exposure rabies prophylaxis among Thai children |
Q35874598 | A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines |
Q45259927 | Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV). |
Q39477334 | Chapter 10 Viral infections of lower motor neurons. |
Q39414342 | Current Status and Development of Vaccines and Other Biologics for Human Rabies Prevention |
Q37635370 | Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals |
Q33889587 | Immunization for children traveling abroad |
Q35104193 | Immunizations for international travel |
Q48025647 | Immunogenicity and booster efficacy of pre-exposure rabies vaccination |
Q54952983 | Immunogenicity and feasibility of intradermal vaccination against rabies in Quebec. |
Q44447203 | Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium |
Q83728751 | Immunogenicity and safety of combined adsorbed low-dose diphtheria, tetanus and inactivated poliovirus vaccine (REVAXIS (®)) versus combined diphtheria, tetanus and inactivated poliovirus vaccine (DT Polio (®)) given as a booster dose at 6 years of |
Q44763423 | Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Viet Nam: results of a comparative randomized trial |
Q92210200 | Inactivated Rabies Virus-Vectored Immunocontraceptive Vaccine in a Thermo-Responsive Hydrogel Induces High and Persistent Antibodies against Rabies, but Insufficient Antibodies against Gonadotropin-Releasing Hormone for Contraception |
Q28829448 | Persistence of Rabies Virus-Neutralizing Antibodies after Vaccination of Rural Population following Vampire Bat Rabies Outbreak in Brazil |
Q35191228 | Persistence of rabies antibody 5 years after postexposure prophylaxis with vero cell antirabies vaccine and antibody response to a single booster dose |
Q73407798 | Pre-exposure rabies vaccination: strategies and cost-minimization study |
Q73713357 | Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: validation of a new booster dose strategy |
Q35714659 | Rabies and other lyssavirus diseases |
Q46302578 | Rabies in France: an update |
Q39246037 | Rabies in travelers |
Q50495857 | Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis. |
Q39084014 | Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans |
Q57235772 | Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults |
Q37445181 | Report of the Fifth AREB Meeting Ho Chi Minh City, Vietnam, 17-20 November 2008. |
Q42183661 | Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis |
Q40285685 | Safety, tolerability and efficacy of intradermal rabies immunization with DebioJect™. |
Q50740222 | Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity. |
Q57029804 | Tollwut: Epidemiologie, prä- und postexpositionelle Immunisierung |
Q34392982 | Travel vaccines and elderly persons: review of vaccines available in the United States. |
Q40611647 | Vaccination in Travelers |
Q47923939 | Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man. |
Search more.